Next Article in Journal
New Devices, Innovative Technologies, and Non-Standard Techniques for Airway Management: A Narrative Review
Previous Article in Journal
Cross-Cultural Adaptation and Psychometric Properties of the Swahili Version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR45 among Breast Cancer Patients in Tanzania
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preliminary Validation of the Revised Illness Perception Questionnaire for Patients with Nasopharyngeal Carcinoma in China

1
School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China
2
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510080, China
3
Department of Social Medicine and Health Education, School of Public Health, Peking University, Beijing 100871, China
4
Shenzhen Kangning Hospital/Shenzhen Mental Health Center, Shenzhen 518020, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Healthcare 2023, 11(18), 2469; https://doi.org/10.3390/healthcare11182469
Submission received: 19 July 2023 / Revised: 15 August 2023 / Accepted: 3 September 2023 / Published: 5 September 2023
(This article belongs to the Section Nutrition and Public Health)

Abstract

:
Nasopharyngeal carcinoma is a common and highly malignant cancer in southern China. It is important to accurately assess the illness perception of nasopharyngeal carcinoma according to the common-sense model of self-regulation. The purpose was to validate the Chinese version of the Revised Illness Perception Questionnaire for patients with Nasopharyngeal carcinoma. A cross-sectional survey of 631 patients with Nasopharyngeal carcinoma was conducted in Guangzhou, China. The reliability of the scale was evaluated using Cronbach’s alpha. The factor structure was assessed using exploratory factor analysis (EFA) of each dimension. The EFA revealed that the 29-item self-rated scale has a seven-factor structure consistent with the original scale and explained 67.3% of the variance after extraction and rotation. The scale showed satisfactory reliability. The item–total correlations ranged from −0.16 to 0.64 (p < 0.05). The item–subscale correlations ranged from 0.46 to 0.91 (p < 0.05). The item–other subscale correlations ranged from −0.38 to 0.51 and from −0.21 to 0.56 (p < 0.05). Significant correlations were found between the timeline (acute/chronic) (r = 0.224, r = 0.166), consequences (r = 0.415, r = 0.338), timeline cyclical (r = 0.366, r = 0.284), emotional representations (r = 0.497, r = 0.465), personal control (r = −0.122, r = −0.134), treatment control (r = −0.135, r = −0.148), and illness coherence (r = −0.261, r = −0.213) subscales, and depression, anxiety (p < 0.05). The scale revealed acceptable reliability, factorial validity, and construct validity. It could be used to assess the illness representations of Chinese patients with nasopharyngeal carcinoma.

1. Introduction

According to the International Agency for Research on Cancer, there were 129,079 new cases of nasopharyngeal carcinoma (NPC) worldwide in 2018 [1], among which 70% were concentrated in east and southeast Asia [1,2]. China’s age-standardized NPC incidence rate was about eight times higher than that of regions with predominantly white populations in 2018 [1,2]. Progress in clinical treatment has remarkably reduced NPC mortality [3] and improved overall survival [4].
NPC patients are at high risk of psychological distress [5] and poor quality of life [6] due to the stigmatizing nature of the facial changes caused by the disease [7], and debilitating therapy, which interfere with social function, speech, eating, cognitive function, and sexual function [8,9]. The incidence of depression and anxiety among NPC patients at the end of radiotherapy is approximately 56% and 64%, respectively [10]. Poor mental health may lead to undesired behaviors [11], including poor adherence to treatment and self-management [12], which further affect physical and mental health [13] and quality of life [14], creating a vicious cycle.
According to the common-sense model of self-regulation [15,16], patients’ illness representation or perception plays an important role in self-regulation. The model suggests that cognitive and emotional elements of illness representations are significantly associated with the coping behaviors, mental health status, and quality of life of patients with hypertension [11], diabetes [17], and cancers, such as chronic lymphocytic leukemia [18], gastrointestinal cancer [19], colorectal cancer [20], and breast cancer [21]. Studies have shown that illness perceptions are associated with depression and anxiety [22]. The consequence dimension of illness perception was shown to be positively correlated with anxiety (r = 0.23, p < 0.05) and depression (r = 0.27, p < 0.05), while the illness coherence dimension was negatively correlated with anxiety (r = −0.47, p < 0.05) and depression (r = −0.26, p < 0.05) [23]. Thus, depression and anxiety were used to test criterion-related validity in this study.
The Illness Perception Questionnaire (IPQ) is the most widely used measurement of illness perception. It is based on Kleinman’s explanatory model of illness and provides a comprehensive explanation of patient perceptions of the diagnosis, treatment, course, cause, and nature of a given disease, which combine to construct their beliefs and understandings from a life course perspective [24]. The Illness Perception Questionnaire-Revised (IPQ-R) was developed to comprehensively assess six dimensions of cognitive representations and one dimension of emotional representations of illness [24,25]. The cognitive dimensions of the IPQ-R include timeline (acute/chronic), consequences, personal control, treatment control, illness coherence, and timeline cyclical. It has been translated into and validated in different languages worldwide for patients with various chronic diseases and has shown good reliability and validity [24].
Patients with different types of cancer may hold different perceptions, beliefs, and experiences. However, there is a lack of literature on the personal experiences of NPC patients. In addition, although a few studies have validated the IPQ-R for patients with cancer, such as breast cancer [26], most were conducted in Western populations [24]. Furthermore, the psychometric properties of the IPQ-R among patients with NPC have not been broadly examined. We identified only four studies that tested the IPQ-R among Chinese patients, specifically those with breast cancer-related lymphedema [27], breast cancer [26], and cervical cancer [28].
The illness perception among cancer patients is related to their cultural background [29]. For example, yin and yang, as a concept in Taoism, has deeply influenced Chinese culture and health beliefs [30]. Traditional Chinese medicine believes that health cannot be achieved without a balance of yin and yang [30]. People in the Chinese culture often believe that the reason they can control the disease is mainly because they fully understand the disease [31]. Furthermore, in China, the distribution of NPC shows obvious geographical differences, with a higher prevalence in southern regions, especially Cantonese-speaking regions Guangdong than in the north [32]. People living in high-risk areas may have a stronger perception of disease risk, in addition to the fact that Guangdong leads the nation in treating NPC. These geographic factors may also influence the illness perception. Thus, given that Chinese NPC patients may have different illness perceptions due to the cultural context and disease-specific characteristics, this study aimed to identify how NPC patients experience the disease and to develop and validate the Chinese version of the Illness Perception Questionnaire Revision for patients with Nasopharyngeal Carcinoma (R-NPC-IPQ) based on the English version of the IPQ-R. We anticipated that the study would shed light on NPC patients’ experiences and thus improve the quality of health services.

2. Materials and Methods

2.1. Participants

A cross-sectional survey was conducted at Sun Yat-sen University Cancer Center (Guangzhou, China). The inclusion criteria were (1) 18 years of age or older, (2) histologically documented diagnosis of NPC, (3) have not ever been diagnosed with any psychiatric disorders, (4) appropriate knowledge of the Chinese language and satisfactory level of communication, and (5) consent to participate in the study. The exclusion criteria included (1) the presence of serious tumors other than NPC, (2) intellectual disability, and (3) inability to complete the questionnaire independently.

2.2. Data Collection

Between patients waiting for their appointments or waiting for radiation therapy, trained research assistants identified and approached eligible patients while distributing the study materials in the outpatient clinic. Investigators briefly introduced himself/herself as the investigator and provided study details (including the purpose of the study, the study sponsoring organization, and the main content of the study) to the patients and asked them if they would like to participate in this survey. The participants were assured that refusal would not affect their medical services at the hospital, and they could quit at any time during the survey without being questioned. If the patient is willing to participate, they will sign a paper consent form prior to the survey. A total of 650 patients were approached, of whom 17 declined to participate, and 633 (response rate: 97.3%) completed the survey. Of the 633 questionnaires collected, two did not pass the logic check, and the remaining 631 participants were included (Figure 1). Ethical approval was obtained from the Ethics Committee of Sun Yat-sen University (No. 2019-145).

2.3. Measures

2.3.1. Development of the Chinese Version of the R-NPC-IPQ

The process of translating and culturally adapting the scale includes the following steps [33]: (1) experts in NPC and psychology reviewed and discussed the item pool, (2) two translators translated the scale into Chinese, (3) experts fluent in both Chinese and English were invited to validate the translation and adapt it to the cultural context of China, (4) we did back translation and compare the back-translated versions of the scale with the original, (5) a draft version of the scale was pretested on 19 patients.
The final version of the R-NPC-IPQ is a 38-item scale containing seven dimensions that evaluate the perceptions and counter-perceptions resulting from the process or experience of coping with cancer: (1) timeline chronic–acute (perceived degree of chronicity of the disease; 6 items), (2) consequences (consequences of the disease for different areas of the patient’s life; 6 items), (3) personal control (perceived ability to control the disease; 6 items), (4) treatment control (perception of the extent to which treatment can control the disease; 5 items), (5) disease coherence (general understanding of the disease; 5 items), (6) timeline periodicity (perceived course of the disease from the periodic appearance of symptoms; 4 items), and (7) emotional representations (emotional burden caused by the disease; 6 items) [34]. Among them, items 1, 4, 8, 15, 17, 18, 19, 23, 24, 25, 26, 27, and 36 are reverse scored. The participants were instructed to score the items on a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree). The total scores ranged from 38 to 190, and higher scores represented higher levels of the relevant dimension. For example, high scores on the emotional representation items indicated high levels of emotional stress.

2.3.2. Generalized Anxiety Disorder 7 (GAD-7)

The Generalized Anxiety Disorder 7 (GAD-7) consists of seven items. It is used primarily to identify potential generalized anxiety and assess its degree. The scale has been widely used in China, with good content and construct validity reported [35]. A 4-point Likert-like scale is used to measure self-reported anxiety levels from 0 (almost never) to 3 (almost every day), with total scores ranging from 0 to 21. The total scores of 0–4, 5–9, 10–14, and 15–21 are often used to classify increasing severity of anxiety. A score of 10 or above indicates anxiety disorder [36]. The Cronbach’s alpha was 0.947 in this study. Higher scores indicate higher levels of anxiety. The total score of this scale will be analyzed by Pearson correlation with the total IPQ score and the scores of each dimension.

2.3.3. Patient Health Questionnaire (PHQ-9)

The Patient Health Questionnaire (PHQ-9) is a 9-item self-administered diagnostic tool to identify the presence of depression. Participants rate their depressive symptoms in the previous two weeks on a 4-point Likert-like scale, ranging from 0 (not at all) to 3 (almost every day). The total score ranges from 0 to 27. The total summed scores of 0–4, 5–9, 10–14, 15–19, and 20–27 are often used to classify non-mild, mild, moderate, moderate-severe, and severe depression, respectively. A score of 10 or above was classified as a depressive disorder [37]. The Chinese version of the PHQ-9 has good psychometric properties among Chinese cancer populations [38]. The Cronbach’s alpha value was 0.915 in this study. Higher scores indicate higher levels of depression. The total score of this scale will be analyzed by Pearson correlation with the total IPQ score and the scores of each dimension.

2.3.4. Demographic Information

Socio-demographic data were collected, including age, gender, education, marital status, occupation, household economic status, and health care payment patterns.

2.4. Statistical Analysis

The data were analyzed using IBM SPSS version 25.0 (IBM Corp., Armonk, NY, USA). All statistical tests were two-sided, and the significance level was set at 0.05. Frequencies, percentages, means, and standard deviations were used for the descriptive analysis. The construct validity of the R-NPC-IPQ was assessed using exploratory factor analysis (EFA) based on a 7-factor model. We conducted Kaiser–Meyer–Olkin (KMO) and Bartlett’s sphericity tests to measure the sampling adequacy and appropriateness of the factor analysis [39].
The factor structure of the IPQ-R was assessed by EFA based on principal component analysis (PCA) with oblique rotation. The factor contributions were assessed using the Kaiser criterion with a cut-off eigenvalue higher than 1.0 and visual inspection of the scree plot. We used breakpoints in the scree plot to determine which figure provided the cleanest and most interpretable structure. Contributing items were identified if their factor loadings were greater than 0.4. To further improve the interpretability of the structure, items with weak loadings (≤0.4) were removed. Any cross-loaded items were assigned to the factor they best fit in terms of conceptual similarity. The internal reliability of the scale was evaluated using Cronbach’s alpha coefficients [39,40].
Pearson correlation analysis was applied to compare item–total correlations, item–subscale correlations, and item–other-subscale correlations within different R-NPC-IPQ subscales. A specific item was properly classified into the current corresponding subscale rather than other subscales if the item–subscale correlations were higher than the item–other-subscale correlations. In addition, the external validity of the R-NPC-IPQ was assessed by examining the Pearson correlation coefficients between the R-NPC-IPQ and two external variables (i.e., GAD-7 and PHQ-9 scores).

3. Results

3.1. Descriptive Statistics

The demographic characteristics of the participants are summarized in Table 1. The participants were aged 18 to 88 years, with a mean of 46.9 years (SD = 11.3 years). Of the 631 participants, 69.1% were male; the majority were married (89.9%); 97.3% were Han Chinese; 59.4% were urban residents; 43.6% were unemployed; 32.3% had an average monthly household income of 3001–5000 RMB; and 31.7% had completed university education. For insurance, 98.6% had medical insurance, and 43.9% had borrowed money due to illness (Table 1).
The mean score of the R-NPC-IPQ was 91.30 (SD = 11.25). The percentage of responses affected by the floor effect for all items ranged from 1.6% to 22.0%. The percentages of responses affected by the ceiling effect ranged from 2.1% to 22.7% (Table 2).
The prevalence of probable depression and anxiety was 45.6% and 35.2%, respectively. The mean scores of the GHQ-9 and GAD-7 were 5.30 (SD = 5.54) and 3.65 (SD = 4.43), respectively.

3.2. Factor Structure

3.2.1. Exploratory Factor Analysis

The results of the Kaiser–Meyer–Olkin (KMO) (0.875) and Bartlett’s tests (χ2 = 9489.501, df = 406, p < 0.001) indicated good factor analysis performance. In the EFA, we identified seven significant factors with eigenvalues greater than 1, which was consistent with the original IPQ-R scale. We removed nine items and re-conducted the PCA with oblique rotation on the remaining 29 items, yielding seven factors. Before the EFA, items 17 and 19 were deleted as they duplicated the meaning of item 16 and item 23, respectively. This improved the overall value of Cronbach’s alpha from 0.718 to 0.740. In the assessment of item contributions, there were five items with factor loadings of 0.4 or below. These were item 1, item 15, item 18, item 23, and item 36. We removed two items (items 4 and 6) that belonged to more than one dimension, The eigenvalues for the seven factors were 7.74, 3.46, 2.33, 1.94, 1.68, 1.28, and 1.11, respectively, explaining 26.7%, 11.9%, 8.0%, 6.7%, 5.8%, 4.4%, and 3.8% of the variance, which together explained 67.3% of the total variance. The factor loadings and contributions of each item are summarized in Table 3.

3.2.2. Item Analysis and Reliability

The Cronbach’s alpha coefficients ranged from 0.73 to 0.92 for the seven dimensions of the scale, which indicates good internal consistency (Table 3). The item–total correlation coefficients ranged from −0.16 to 0.64 (p < 0.05, Table 4). The item–subscale correlation coefficients ranged from 0.46 to 0.91 (p < 0.05, Table 4). Moderately strong correlations were detected between the subscales. The item–other-subscale correlation coefficients ranged from −0.38 to 0.56 (p < 0.05, Table 4). The mean total scores of the seven dimensions were 7.82 (SD = 3.03), 15.20 (SD =3.89), 13.02 (SD = 2.99), 11.07 (SD = 2.13), 15.77 (SD = 3.77), 9.93 (SD = 3.24), and 13.95 (SD = 4.58), respectively (Table 5).

3.2.3. External Correlation

Regarding external validity (Table 6), chronic timeline, consequences, higher timeline cycle, and emotional representations showed mild to moderate positive correlations with depression (r = 0.224, 0.415, 0.366, and 0.497, respectively, p < 0.05) and anxiety (r = 0.166, 0.338, 0.284, and 0.465, respectively, p < 0.05), while personal control, treatment control, and illness coherence showed mild negative correlations with depression (r = −0.122, −0.135, −0.261, respectively, p < 0.05) and anxiety (r = −0.134, −0.148, −0.213, respectively, p < 0.05). The external correlations with depression and anxiety are summarized in Table 6.

4. Discussion

We conducted EFA on data from 631 patients with NPC to validate the structural and content validity of the R-NPC-IPQ. The results confirmed that the 29-item R-NPC-IPQ possessed satisfactory factorial validity, external validity, and internal reliability. This is the first study to investigate illness representation and IPQ-R use among NPC patients in China and to report reliable results. The GAD-7 and PHQ-9 showed good reliability in this study, which similarly confirmed the high prevalence of anxiety and depression in patients with NPC.
The removal of items 1, 4, 6, 15, 17, 18, 19, 23, and 36 would improve the structural validity of the IPQ-R given the weak factor loadings and cross factor loadings, a finding similar to IPQ-R validation studies among patients with Internet gaming disorder [41], type 2 diabetes [42], and cervical cancer [28]. Most of the removed items were reverse-scored. Other researchers have encountered similar problems and eventually removed items with reversed wording. Although reversed items are commonly used to prevent response biases, researchers have pointed out that they may weaken scale validity because the responses to reversed items are more prone to errors due to inattention and confusion [43]. Cultural differences may also contribute to the poor performance of the removed items. For instance, item 18 from the timeline chronic factor, “My NPC will improve in time,” is difficult to understand and ambiguous in different cultural contexts. In Chinese culture, patients often adapt to health threats by adopting strategies such as “seeking bliss” and “letting fate take its course”, believing that agreeing with negative aspects will lead to correspondingly undesirable outcomes [43]. Thus, they may interpret statements such as item 15, “Nothing I do will affect my NPC”, and item 23, “There is nothing that can help my condition” as unwanted fatalism and intentionally underscore these items while intentionally overscoring those items conveying positive expectations such as item 18, “My NPC will improve in time”, and item 36, “My NPC does not worry me”.
Patients with NPC are exposed to severe stigma and several types of stressors. It was not surprising that we found a high prevalence of probable depression and anxiety in this study sample, which was consistent with studies conducted in Western countries [44]. Positive correlations were found between mental health problems and the consequences, illness coherence, timeline cycle, and emotional representation factors. This finding was supported by the common-sense model of self-regulation, which posits that cognitive and emotional representations play an important role in self-regulation among patients facing health threats, which further affects their mental health and quality of life. Studies have also found that these factors were positively associated with depression and anxiety among patients with breast cancer [45], type 2 diabetes [46], and head and neck cancer [47]. The findings suggest that reducing misunderstanding and improving knowledge about NPC and its treatments may reduce mental health problems. The personal control factor was negatively associated with depression, suggesting that a higher level of perceived personal control is a protective factor. Interventions are warranted to increase patients’ self-efficacy in managing their illness.
The 29-item modified R-NPC-IPQ showed satisfactory psychometric properties compared with the original IPQ-R in terms of internal consistency, factorial validity, and external validity. The Cronbach’s alphas of the modified scale ranged from 0.73 to 0.92, higher than that of the original IPQ-R. Factor analysis yielded seven significant factors with satisfactory eigenvalues, which was consistent with the original IPQ-R scales and other IPQ-R validation studies among cancer patients, such as those with breast cancer. The mild to moderate inter-factor correlations confirmed that each factor measured a distinct construct of illness representation. External validity was supported by the significant positive correlations of depression and anxiety with the factors for chronic timeline, consequences, higher timeline cycle, and emotional representations, and their negative correlations with personal control, treatment control, and illness coherence.
This study is the first to validate the IPQ-R with a relatively large sample of patients with NPC. However, it has several limitations. First, our sample was recruited from an outpatient clinic. Thus, the results cannot be generalized to hospitalized patients with NPC due to the difference in clinical severity. Further validation studies are greatly warranted to test the factor structure of the IPQ with NPC inpatients. Second, the findings may not be generalizable to Western populations due to cultural differences. Third, causal inferences cannot be made as we used a cross-sectional study design. Fourth, test–retest reliability was not validated in this study. Furthermore, confirmatory factor analysis (CFA) and test-retest reliability analyses were not performed in this study. We hope that future studies using this scale will conduct further analyses.

5. Conclusions

In conclusion, the modified 29-item R-NPC-IPQ has acceptable reliability and validity and is suitable for assessing the illness representations of Chinese patients with NPC. This study explored the associations between cognitive and emotional perceptions with mental health outcomes. Using this validated scale, future research is warranted to examine the mechanism by which illness representations of NPC influence patients’ behaviors and then further affect their mental health and quality of life. Studies to develop and test the efficacy of interventions to modify illness representations are also warranted.

Author Contributions

Conceptualization, J.L. and F.H.; methodology, Y.C., W.C. and V.Y.G.; software, F.H.; validation, Y.C., Y.Z. (Yuan Zhang), W.C., V.Y.G., Y.D., L.L., J.S., Y.Z. (Yang Zhu), X.C., X.Y., F.H. and J.L.; formal analysis, Y.C.; investigation, W.C., V.Y.G., Y.D., L.L., J.S., Y.Z. (Yang Zhu), X.C. and X.Y.; resources, Y.Z. (Yuan Zhang); data curation, Y.D.; writing—original draft preparation, Y.C. and Y.D.; writing—review and editing, Y.C., Y.Z., W.C., V.Y.G., Y.D., L.L., J.S., Y.Z. (Yang Zhu), X.C., X.Y., F.H. and J.L.; supervision, J.L.; project administration, Y.Z. (Yuan Zhang) and J.L.; funding acquisition, F.H. and J.L. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (SZGSP013), Guangdong Natural Science Foundation (2214050008343), Sun Yat-Sen University Young Teacher Incubation Foundation of China (20ykpy84).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Sun Yat-sen University (No. 2019-145).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data cannot be shared publicly because of the privacy implication, but is available upon resonable request. Data requests may be sent to the corresponding author.

Acknowledgments

The authors would like to acknowledge all participants in this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
  2. Chen, Y.P.; Chan, A.T.C.; Le, Q.T.; Blanchard, P.; Sun, Y.; Ma, J. Nasopharyngeal carcinoma. Lancet 2019, 394, 64–80. [Google Scholar] [CrossRef] [PubMed]
  3. Wei, K.R.; Zheng, R.S.; Zhang, S.W.; Liang, Z.H.; Li, Z.M.; Chen, W.Q. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin. J. Cancer 2017, 36, 90. [Google Scholar] [CrossRef] [PubMed]
  4. Ji, M.F.; Sheng, W.; Cheng, W.M.; Ng, M.H.; Wu, B.H.; Yu, X.; Wei, K.R.; Li, F.G.; Lian, S.F.; Wang, P.P.; et al. Incidence and mortality of nasopharyngeal carcinoma: Interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Ann. Oncol. 2019, 30, 1630–1637. [Google Scholar] [CrossRef]
  5. Götze, H.; Friedrich, M.; Taubenheim, S.; Dietz, A.; Lordick, F.; Mehnert, A. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support. Care Cancer 2020, 28, 211–220. [Google Scholar] [CrossRef]
  6. Chan, Y.W.; Chow, V.L.; Wei, W.I. Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Cancer 2012, 118, 3710–3718. [Google Scholar] [CrossRef]
  7. Cho, J.; Fingeret, M.C.; Huang, S.C.; Liu, J.; Reece, G.P.; Markey, M.K. Observers’ response to facial disfigurement from head and neck cancer. Psychooncology 2018, 27, 2119–2124. [Google Scholar] [CrossRef]
  8. McDowell, L.; So, N.; Keshavarzi, S.; Xu, W.; Rock, K.; Chan, B.; Waldron, J.; Bernstein, L.J.; Hui Huang, S.; Giuliani, M.; et al. Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants. Oral. Oncol. 2020, 109, 104865. [Google Scholar] [CrossRef]
  9. Li, H.; Li, L.; Huang, X.; Li, Y.; Zou, T.; Zhuo, X.; Chen, Y.; Liu, Y.; Tang, Y. Radiotherapy-induced dysphagia and its impact on quality of life in patients with nasopharyngeal carcinoma. Strahlenther. Onkol. 2019, 195, 457–467. [Google Scholar] [CrossRef]
  10. Wang, C.; Chen, J.; Su, L.; Hua, Y.; Ye, J.; Song, X.; Lv, W.; Zhang, M.; Huang, F.; Tian, J.; et al. The psychological status in patients with nasopharyngeal carcinoma during radiotherapy. Eur. Arch. Otorhinolaryngol. 2022, 279, 1035–1042. [Google Scholar] [CrossRef]
  11. Chen, S.L.; Tsai, J.C.; Chou, K.R. Illness perceptions and adherence to therapeutic regimens among patients with hypertension: A structural modeling approach. Int. J. Nurs. Stud. 2011, 48, 235–245. [Google Scholar] [CrossRef] [PubMed]
  12. Aujla, N.; Walker, M.; Sprigg, N.; Abrams, K.; Massey, A.; Vedhara, K. Can illness beliefs, from the common-sense model, prospectively predict adherence to self-management behaviours? A systematic review and meta-analysis. Psychol. Health 2016, 31, 931–958. [Google Scholar] [CrossRef] [PubMed]
  13. Hu, L.Y.; Ku, F.C.; Wang, Y.P.; Shen, C.C.; Hu, Y.W.; Yeh, C.M.; Chen, P.M.; Chiang, H.L.; Lu, T.; Chen, T.J.; et al. Anxiety and depressive disorders among patients with esophageal cancer in Taiwan: A nationwide population-based study. Support. Care Cancer 2015, 23, 733–740. [Google Scholar] [CrossRef] [PubMed]
  14. van der Hout, A.; van Uden-Kraan, C.F.; Holtmaat, K.; Jansen, F.; Lissenberg-Witte, B.I.; Nieuwenhuijzen, G.A.P.; Hardillo, J.A.; Baatenburg de Jong, R.J.; Tiren-Verbeet, N.L.; Sommeijer, D.W.; et al. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: A randomised, controlled trial. Lancet Oncol. 2020, 21, 80–94. [Google Scholar] [CrossRef] [PubMed]
  15. Hagger, M.S.; Koch, S.; Chatzisarantis, N.L.D.; Orbell, S. The common sense model of self-regulation: Meta-analysis and test of a process model. Psychol. Bull. 2017, 143, 1117–1154. [Google Scholar] [CrossRef] [PubMed]
  16. Leventhal, H.; Phillips, L.A.; Burns, E. The Common-Sense Model of Self-Regulation (CSM): A dynamic framework for understanding illness self-management. J. Behav. Med. 2016, 39, 935–946. [Google Scholar] [CrossRef]
  17. Li, J.; Qiu, X.; Yang, X.; Zhou, J.; Zhu, X.; Zhao, E.; Qiao, Z.; Yang, Y.; Cao, D. Relationship between Illness Perception and Depressive Symptoms among Type 2 Diabetes Mellitus Patients in China: A Mediating Role of Coping Style. J. Diabetes Res. 2020, 2020, 3142495. [Google Scholar] [CrossRef]
  18. Westbrook, T.D.; Maddocks, K.; Andersen, B.L. The relation of illness perceptions to stress, depression, and fatigue in patients with chronic lymphocytic leukaemia. Psychol. Health 2016, 31, 891–902. [Google Scholar] [CrossRef]
  19. Miceli, J.; Geller, D.; Tsung, A.; Hecht, C.L.; Wang, Y.; Pathak, R.; Cheng, H.; Marsh, W.; Antoni, M.; Penedo, F.; et al. Illness perceptions and perceived stress in patients with advanced gastrointestinal cancer. Psychooncology 2019, 28, 1513–1519. [Google Scholar] [CrossRef]
  20. Thong, M.S.; Kaptein, A.A.; Vissers, P.A.; Vreugdenhil, G.; van de Poll-Franse, L.V. Illness perceptions are associated with mortality among 1552 colorectal cancer survivors: A study from the population-based PROFILES registry. J. Cancer Surviv. 2016, 10, 898–905. [Google Scholar] [CrossRef]
  21. Kus, T.; Aktas, G.; Ekici, H.; Elboga, G.; Djamgoz, S. Illness perception is a strong parameter on anxiety and depression scores in early-stage breast cancer survivors: A single-center cross-sectional study of Turkish patients. Support. Care Cancer 2017, 25, 3347–3355. [Google Scholar] [CrossRef] [PubMed]
  22. Fu, M.R.; Ridner, S.H.; Hu, S.H.; Stewart, B.R.; Cormier, J.N.; Armer, J.M. Psychosocial impact of lymphedema: A systematic review of literature from 2004 to 2011. Psychooncology 2013, 22, 1466–1484. [Google Scholar] [CrossRef] [PubMed]
  23. Keeling, M.; Bambrough, J.; Simpson, J. Depression, anxiety and positive affect in people diagnosed with low-grade tumours: The role of illness perceptions. Psychooncology 2013, 22, 1421–1427. [Google Scholar] [CrossRef] [PubMed]
  24. Broadbent, E.; Wilkes, C.; Koschwanez, H.; Weinman, J.; Norton, S.; Petrie, K.J. A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol. Health 2015, 30, 1361–1385. [Google Scholar] [CrossRef] [PubMed]
  25. Giannousi, Z.; Manaras, I.; Georgoulias, V.; Samonis, G. Illness perceptions in Greek patients with cancer: A validation of the Revised-Illness Perception Questionnaire. Psychooncology 2010, 19, 85–92. [Google Scholar] [CrossRef] [PubMed]
  26. Zhang, N.; Fielding, R.; Soong, I.; Chan, K.K.; Lee, C.; Ng, A.; Sze, W.K.; Tsang, J.; Lee, V.; Lam, W.W. Psychometric assessment of the Chinese version of the brief illness perception questionnaire in breast cancer survivors. PLoS ONE 2017, 12, e0174093. [Google Scholar] [CrossRef]
  27. Huang, W.; Zhang, L.; Yan, J. Psychometric evaluation of the Chinese version of the revised illness perception questionnaire for breast cancer-related lymphedema. Eur. J. Cancer Care 2019, 28, e12900. [Google Scholar] [CrossRef]
  28. Chen, J.; Zhang, H.; Suo, R.; Xiong, C.; Zhang, X.; Zhang, Y.; Yan, J. Adaptation and psychometric testing of the Chinese version of the Revised Illness Perception Questionnaire for cervical cancer patients. Eur. J. Oncol. Nurs. 2020, 48, 101799. [Google Scholar] [CrossRef]
  29. Dein, S. Explanatory models of and attitudes towards cancer in different cultures. Lancet Oncol. 2004, 5, 119–124. [Google Scholar] [CrossRef]
  30. Chew, K.S.; Tan, T.W.; Ooi, Y.T. Influence of Chinese cultural health beliefs among Malaysian Chinese in a suburban population: A survey. Singapore Med. J. 2011, 52, 252–256. [Google Scholar]
  31. Fan, Y.; Huang, Z.; Zhang, D.; Chang, J.; Jia, Y.; He, S.; Wei, B. Psychometric validation of the Chinese version of the Illness Perception Questionnaire-Revised for women with stress urinary incontinence. J. Obstet. Gynaecol. Res. 2017, 43, 1305–1316. [Google Scholar] [CrossRef] [PubMed]
  32. Cao, S.M.; Simons, M.J.; Qian, C.N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin. J. Cancer 2011, 30, 114–119. [Google Scholar] [CrossRef]
  33. Wild, D.; Grove, A.; Martin, M.; Eremenco, S.; McElroy, S.; Verjee-Lorenz, A.; Erikson, P. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005, 8, 94–104. [Google Scholar] [CrossRef] [PubMed]
  34. Broadbent, E.; Petrie, K.J.; Main, J.; Weinman, J. The brief illness perception questionnaire. J. Psychosom. Res. 2006, 60, 631–637. [Google Scholar] [CrossRef] [PubMed]
  35. Shi, L.; Lu, Z.A.; Que, J.Y.; Huang, X.L.; Liu, L.; Ran, M.S.; Gong, Y.M.; Yuan, K.; Yan, W.; Sun, Y.K.; et al. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic. JAMA Netw. Open 2020, 3, e2014053. [Google Scholar] [CrossRef] [PubMed]
  36. Spitzer, R.L.; Kroenke, K.; Williams, J.B.; Löwe, B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 2006, 166, 1092–1097. [Google Scholar] [CrossRef]
  37. Kroenke, K.; Spitzer, R.L.; Williams, J.B. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16, 606–613. [Google Scholar] [CrossRef]
  38. Sun, X.Y.; Li, Y.X.; Yu, C.Q.; Li, L.M. [Reliability and validity of depression scales of Chinese version: A systematic review]. Zhonghua Liu Xing Bing Xue Za Zhi 2017, 38, 110–116. [Google Scholar] [CrossRef]
  39. Gaskin, C.J.; Happell, B. On exploratory factor analysis: A review of recent evidence, an assessment of current practice, and recommendations for future use. Int. J. Nurs. Stud. 2014, 51, 511–521. [Google Scholar] [CrossRef]
  40. Izquierdo, I.; Olea, J.; Abad, F.J. Exploratory factor analysis in validation studies: Uses and recommendations. Psicothema 2014, 26, 395–400. [Google Scholar] [CrossRef]
  41. Lau, J.T.F.; Dang, L.; Cheung, R.Y.H.; Zhang, M.X.; Chen, J.H.; Wu, A.M.S. The psychometric properties of the Revised Illness Perception Questionnaire (IPQ-R) regarding Internet gaming disorder in a general population of Chinese adults. J. Behav. Addict. 2020, 9, 654–663. [Google Scholar] [CrossRef] [PubMed]
  42. Brzoska, P.; Yilmaz-Aslan, Y.; Sultanoglu, E.; Sultanoglu, B.; Razum, O. The factor structure of the Turkish version of the Revised Illness Perception Questionnaire (IPQ-R) in patients with diabetes and cardiovascular disease. BMC Public Health 2012, 12, 852. [Google Scholar] [CrossRef] [PubMed]
  43. Chen, S.L.; Tsai, J.C.; Lee, W.L. Psychometric validation of the Chinese version of the Illness Perception Questionnaire-Revised for patients with hypertension. J. Adv. Nurs. 2008, 64, 524–534. [Google Scholar] [CrossRef] [PubMed]
  44. So, N.; McDowell, L.J.; Lu, L.; Xu, W.; Rock, K.; Waldron, J.; Bernstein, L.J.; Chan, H.B.; Huang, S.H.; Giuliani, M.; et al. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors. Int. J. Radiat. Oncol. Biol. Phys. 2020, 106, 134–145. [Google Scholar] [CrossRef]
  45. Gibbons, A.; Groarke, A.; Sweeney, K. Predicting general and cancer-related distress in women with newly diagnosed breast cancer. BMC Cancer 2016, 16, 935. [Google Scholar] [CrossRef]
  46. Huang, Y.C.; Zuñiga, J.; García, A. Illness perceptions as a mediator between emotional distress and management self-efficacy among Chinese Americans with type 2 diabetes. Ethn. Health 2022, 27, 672–686. [Google Scholar] [CrossRef]
  47. Esser, P.; Mehnert, A.; Johansen, C.; Hornemann, B.; Dietz, A.; Ernst, J. Body image mediates the effect of cancer-related stigmatization on depression: A new target for intervention. Psychooncology 2018, 27, 193–198. [Google Scholar] [CrossRef]
Figure 1. Flow chart of recruitment.
Figure 1. Flow chart of recruitment.
Healthcare 11 02469 g001
Table 1. Demographic characteristics of the samples with NPC (n = 631).
Table 1. Demographic characteristics of the samples with NPC (n = 631).
Socio-Demographic VariablesLevelsn (%)
Age<40 years old179 (28.4)
40–59 years old370 (58.6)
60–85 years old82 (13.0)
SexMale436 (69.1)
Female195 (30.9)
EthnicityHan Chinese614 (97.3)
Other17 (2.7)
ResidenceUrban375 (59.4)
Rural256 (40.6)
MarriageCurrently Unmarried64 (10.1)
Currently Married567 (89.9)
Primary CaregiverSpouse443 (70.2)
Children99 (15.7)
Parent and Siblings65 (10.3)
Myself24 (3.8)
EducationJunior High School and below287 (45.5)
High School144 (22.8)
University and above200 (31.7)
OccupationFull-time and Part-time279 (44.2)
Retired77 (12.2)
Unemployed223 (35.3)
Other52 (8.2)
Average Monthly IncomeLess than 3000 RMB164 (26.0)
3001–5000 RMB204 (32.3)
5001–10,000 RMB160 (25.4)
Above 10,000 RMB103 (16.3)
Type of Medical InsuranceUrban Employee-Based Medical Insurance243 (38.5)
Urban Resident-Based Medical Insurance164 (26.0)
New Cooperative Medical Scheme215 (34.1)
No Medical Insurance9 (1.4)
Borrowing Money for IllnessYes277 (43.9)
No354 (56.1)
Table 2. Descriptive statistics for the items in the R-NPC-IPQ (N = 631).
Table 2. Descriptive statistics for the items in the R-NPC-IPQ (N = 631).
SubscalesItemsScore RangeMean 1SD 2Floor
Effect 3 (%)
Ceiling Effect 3 (%)Skewness 4Kurtosis 4
Timing (acute/chronic)1. My NPC will last a short time1~52.681.14114.39.70.474−0.418
2. My NPC is likely to be permanent rather than temporary1~52.631.13019.55.10.159−0.762
3. My NPC will last for a long time1~52.681.10417.04.30.093−0.792
4. This NPC will pass quickly1~52.571.06114.76.80.535−0.063
5. I expect to have this NPC for the rest of my life1~52.511.12822.04.80.328−0.678
18. My NPC will improve in time1~52.510.93910.04.40.7190.473
Consequences6. My NPC is a serious condition1~52.531.10520.04.02.531.105
7. My NPC has major consequences on my life1~52.821.13914.36.02.821.139
8. My NPC does not have much effect on my life1~53.231.1347.313.33.231.134
9. My NPC strongly affects the way others see me1~52.731.08315.84.12.731.083
10. My NPC has serious financial consequences1~53.451.1337.117.13.451.133
11. My NPC causes difficulties for those who are close to me1~52.981.09710.66.02.981.097
Personal Control12. There is a lot I can do to control my symptoms1~53.160.9716.75.9−0.380−0.115
13. What I do can determine whether my NPC gets better or worse1~53.390.9674.98.7−0.5850.072
14. The course of my NPC depends on me1~53.270.9545.16.0−0.502−0.111
15. Nothing I do will affect my NPC1~53.580.9872.517.7−0.417−0.259
16. I have the power to influence my NPC1~53.201.0096.76.7−0.408−0.336
17. My actions will have no effect on the outcome of my NPC1~53.490.9591.913.8−0.292−0.415
Treatment Control19. There is very little that can be done to improve my NPC1~53.261.0164.012.5−0.057−0.452
20. My treatment will be effective in curing my NPC1~53.730.8271.914.6−0.7191.066
21. The negative effects of my NPC can be prevented (avoided) by my treatment1~53.620.8322.111.3−0.6210.798
22. My treatment can control my NPC1~53.720.8392.412.5−0.9491.406
23. There is nothing that can help my condition1~53.760.9491.622.7−0.547−0.082
Illness Coherence24. The symptoms of my condition are puzzling to me1~52.991.0094.18.70.299−0.501
25. My NPC is a mystery to me1~53.171.0424.011.60.065−0.663
26. I don’t understand my NPC1~53.231.0132.911.30.022−0.682
27. My NPC doesn’t make any sense to me1~53.191.0093.810.1−0.006−0.557
28. I have a clear picture or understanding of my condition1~53.200.9625.95.9−0.408−0.135
Timeline Cyclical29. The symptoms of my NPC change a great deal from day to day1~52.660.99213.02.90.101−0.476
30. My symptoms come and go in cycles1~52.370.96918.12.20.488−0.154
31. My NPC is very unpredictable1~52.530.98215.22.40.240−0.417
32. I go through cycles in which my NPC gets better and worse.1~52.380.96618.22.10.430−0.227
Emotional Representation33. I get depressed when I think about my NPC1~52.721.06513.53.60.084−0.782
34. When I think about my NPC, I get upset1~52.731.07113.34.60.132−0.689
35. My NPC makes me feel angry1~52.721.02811.93.80.123−0.595
36. My NPC does not worry me1~53.111.0636.310.3−0.024−0.588
37. Having this NPC makes me feel anxious1~52.921.0519.84.4−0.121−0.749
38. My NPC makes me feel afraid1~52.851.06511.74.6−0.063−0.716
1 Mean, simple arithmetic mean, describes the centralized trend of item scores; 2 SD, standard deviation, describes the dispersion trend of item scores. 3 Floor Effect (%) and Ceiling Effect (%) describe the sensitivity of questionnaire items to experimenters under such experimental conditions. 4 Skewness and Kurtosis describe the symmetry and steepness of item scores distribution.
Table 3. Exploratory factor analysis of the R-NPC-IPQ items and factor loadings of the final model.
Table 3. Exploratory factor analysis of the R-NPC-IPQ items and factor loadings of the final model.
SubscalesItemsFactor 1Factor 2Factor 3Factor 4Factor 5Factor 6Factor 7
Emotional Representation37. Having this NPC makes me feel anxious0.9070.029−0.0590.059−0.0230.0430.016
34. When I think about my NPC I get upset0.886−0.042−0.026−0.0350.049−0.0060.010
38. My NPC makes me feel afraid0.8560.0060.0140.0190.0090.0190.004
35. My NPC makes me feel angry0.8430.0350.017−0.073−0.038−0.067−0.013
33. I get depressed when I think about my NPC0.760−0.0240.034−0.0160.0870.083−0.007
Personal Control13. What I do can determine whether my NPC gets better or worse0.0230.8300.0410.0020.0110.0110.011
14. The course of my NPC depends on me−0.0530.8120.066−0.027−0.0100.138−0.044
16. I have the power to influence my NPC0.0650.751−0.088−0.033−0.028−0.1220.000
12. There is a lot I can do to control my symptoms−0.0180.663−0.0190.012−0.0520.0210.033
Timeline (acute/chronic)2. My NPC is likely to be permanent rather than temporary0.002−0.0520.903−0.032−0.043−0.049−0.008
3. My NPC will last for a long time−0.0110.0440.880−0.0090.0050.013−0.075
5. I expect to have this NPC for the rest of my life−0.0120.0230.862−0.0200.0380.009−0.108
Illness Coherence26. I don’t understand my NPC−0.0080.033−0.0730.863−0.046−0.033−0.029
27. My NPC doesn’t make any sense to me−0.020−0.0360.0040.849−0.0160.0230.012
25. My NPC is a mystery to me−0.064−0.019−0.0260.810−0.0930.008−0.101
24. The symptoms of my condition are puzzling to me−0.034−0.080−0.0440.654−0.166−0.035−0.048
28. I have a clear picture or understanding of my condition0.0010.1570.1350.4580.376−0.0670.302
Timeline Cyclical29. The symptoms of my NPC change a great deal from day to day−0.072−0.013−0.080−0.0190.8020.0790.017
30. My symptoms come and go in cycles0.098−0.0610.016−0.0790.7640.014−0.087
31. My NPC is very unpredictable0.090−0.0330.068−0.1790.7210.021−0.089
32. I go through cycles in which my NPC gets better and worse.0.267−0.0970.073−0.1030.634−0.033−0.113
Consequences11. My NPC causes difficulties for those who are close to me0.0720.1420.015−0.0510.0010.7520.022
10. My NPC has serious financial consequences−0.0360.032−0.016−0.1150.1070.7330.123
8. My NPC does not have much effect on my life0.067−0.045−0.1120.1020.0290.583−0.257
7. My NPC has major consequences on my life0.139−0.0880.3110.001−0.0200.5370.044
9. My NPC strongly affects the way others see me0.169−0.0990.328−0.027−0.0540.4320.106
Treatment Control20. My treatment will be effective in curing my NPC0.0390.014−0.083−0.015−0.079−0.0870.835
22. My treatment can control my NPC−0.0200.010−0.050−0.0080.0220.0300.830
21. The negative effects of my NPC can be prevented (avoided) by my treatment−0.0190.044−0.061−0.049−0.0730.0700.786
Cronbach’s Alpha 0.9170.7680.8840.8030.8470.7340.809
Initial Eigenvalues 7.7393.4552.3321.9371.6771.2791.112
Cumulative % of variance explained26.68638.59946.64053.32059.10463.51267.346
Note: Extraction Method: Principal Component Analysis. Rotation Method: Direct Oblimin with Kaiser Normalization. Bolded content indicates loadings greater than 0.4.
Table 4. Item analysis of the of the R-NPC-IPQ.
Table 4. Item analysis of the of the R-NPC-IPQ.
SubscalesItemsCronbach’s Alpha if Item is DeletedItem-Total CorrelationItem-Subscale CorrelationItem-Other-Subscale Correlation
SubscaleTotal
Timeline (acute/chronic)2. My NPC is likely to be permanent rather than temporary0.8350.7240.444 **0.902 **−0.182 **–0.325 **
3. My NPC will last for a long time0.8300.7200.499 **0.902 **−0.054–0.383 **
5. I expect to have this NPC for the rest of my life0.8410.7210.484 **0.899 **−0.095 *–0.381 **
Consequences7. My NPC has major consequences on my life0.6480.7140.571 **0.767 **−0.079 *–0.442 **
8. My NPC does not have much effect on my life0.7450.7330.319 **0.588 **−0.231 **–0.282**
9. My NPC strongly affects the way others see me0.6900.7180.523 **0.687 **−0.067–0.419 **
10. My NPC has serious financial consequences0.6920.7200.498 **0.691 **−0.243 **–0.361 **
11. My NPC causes difficulties for those who are close to me0.6570.7160.555 **0.749 **−0.214 **–0.394 **
Personal Control12. There is a lot I can do to control my symptoms0.7530.7420.150 **0.716 **−0.102 *–0.337 **
13. What I do can determine whether my NPC gets better or worse0.6700.7350.260 **0.814 **−0.089 *–0.384 **
14. The course of my NPC depends on me0.7000.7350.272 **0.779 **−0.092 *–0.331 **
16. I have the power to influence my NPC0.7230.7440.125 **0.762 **−0.162 **–0.377 **
Treatment Control20. My treatment will be effective in curing my NPC0.7050.7430.080 *0.866 **−0.233 **–0.395 **
21. The negative effects of my NPC can be prevented (avoided) by my treatment0.7690.7400.152 **0.835 **−0.176 **–0.407 **
22. My treatment can control my NPC0.7410.7390.168 **0.851 **−0.167 **–0.387 **
Illness Coherence24. The symptoms of my condition are puzzling to me0.7740.760−0.164 **0.729 **−0.366 **–0.003
25. My NPC is a mystery to me0.7230.759−0.129 **0.836 **−0.382 **–−0.003
26. I don’t understand my NPC0.7020.757−0.105 **0.875 **−0.377 **–0.069
27. My NPC doesn’t make any sense to me0.7270.754−0.0440.828 **−0.318 **–0.043
28. I have a clear picture or understanding of my condition0.8650.7340.276 **0.456 **−0.051–0.268 **
Timeline Cyclical29. The symptoms of my NPC change a great deal from day to day0.8680.7280.380 **0.735 **−0.181 **–0.278 **
30. My symptoms come and go in cycles0.7750.7220.474 **0.868 **−0.303 **–0.439 **
31. My NPC is very unpredictable0.7840.7220.481 **0.857 **−0.383 **–0.469 **
32. I go through cycles in which my NPC gets better and worse.0.7860.7200.508 **0.853 **−0.208 **–0.559 **
Emotional Representation33. I get depressed when I think about my NPC0.9020.7100.635 **0.859 **−0.358 **–0.518 **
34. When I think about my NPC, I get upset0.8840.7110.615 **0.914 **−0.383 **–0.508 **
35. My NPC makes me feel angry0.9100.7170.544 **0.827 **−0.366 **–0.416 **
37. Having this NPC makes me feel anxious0.8980.7120.610 **0.871 **−0.291 **–0.469 **
38. My NPC makes me feel afraid0.9000.7120.612 **0.864 **−0.323 **–0.478 **
* p < 0.05, ** p < 0.01. Item-total correlation: Pearson correlation coefficient between each item and the overall scale. Item-subscale correlation: Pearson correlation coefficient between each item and its corresponding subscale. Item-other-subscale correlation: Pearson correlation coefficient between each item and the other subscale.
Table 5. Pearson correlation of the R-NPC-IPQ dimensions.
Table 5. Pearson correlation of the R-NPC-IPQ dimensions.
SubscaleItem NumberRangeMeanSD1234567
Subscale 1: Timeline (acute/chronic)33–157.823.031
Subscale 2: Consequences55–2515.203.890.403 **1
Subscale 3: Personal control44–2013.022.99−0.099 *−0.0371
Subscale 4: Treatment control items33–1511.072.13−0.226 **−0.140 **0.466 **1
Subscale 5: Illness coherence items55–2515.773.77−0.183 **−0.287 **0.0700.096 *1
Subscale 6: Timeline cyclical44–209.933.240.279 **0.358 **−0.156 **−0.146 **−0.371 **1
Subscale 7: Emotional representations55–2513.954.580.302 **0.545 **−0.136 **−0.123 **−0.397 **0.526 **1
* p < 0.05, ** p < 0.01. Mean, simple arithmetic mean, describes the centralized trend of item scores; SD, standard deviation, describes the dispersion trend of item scores.
Table 6. Pearson correlation among the R-NPC-IPQ dimensions and other related variables.
Table 6. Pearson correlation among the R-NPC-IPQ dimensions and other related variables.
Illness Perception Questionnaire SubscaleDepressionAnxiety
Subscale 1: Timeline (acute/chronic)0.224 **0.166 **
Subscale 2: Consequences0.415 **0.338 **
Subscale 3: Personal control−0.122 **−0.134 **
Subscale 4: Treatment control−0.135 **−0.148 **
Subscale 5: Illness coherence−0.261 **−0.213 **
Subscale 6: Timeline cyclical0.366 **0.284 **
Subscale 7: Emotional representations0.497 **0.465 **
** p < 0.01.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cai, Y.; Zhang, Y.; Cao, W.; Guo, V.Y.; Deng, Y.; Luo, L.; Shen, J.; Zhu, Y.; Chen, X.; Yang, X.; et al. Preliminary Validation of the Revised Illness Perception Questionnaire for Patients with Nasopharyngeal Carcinoma in China. Healthcare 2023, 11, 2469. https://doi.org/10.3390/healthcare11182469

AMA Style

Cai Y, Zhang Y, Cao W, Guo VY, Deng Y, Luo L, Shen J, Zhu Y, Chen X, Yang X, et al. Preliminary Validation of the Revised Illness Perception Questionnaire for Patients with Nasopharyngeal Carcinoma in China. Healthcare. 2023; 11(18):2469. https://doi.org/10.3390/healthcare11182469

Chicago/Turabian Style

Cai, Yuqi, Yuan Zhang, Wangnan Cao, Vivian Yawei Guo, Yang Deng, Liying Luo, Jianling Shen, Yang Zhu, Xiaoting Chen, Xiao Yang, and et al. 2023. "Preliminary Validation of the Revised Illness Perception Questionnaire for Patients with Nasopharyngeal Carcinoma in China" Healthcare 11, no. 18: 2469. https://doi.org/10.3390/healthcare11182469

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop